Deal Announcements

BioAnalytix Lands Venture Capital Funding

Monday, August 20, 2012 5:35:00 AM PDT | VentureDeal

Boston, Massachusetts -- Biotechnology company BioAnalytix (no website) has received $850,000 in new venture capital funding.

BioAnalytix is developing analysis technologies for large-molecule biologic drugs and biosimilars.

Relativity Capital led the round, which included other undisclosed investors.

Proceeds purposes were not disclosed.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1